Previous Page  5 / 5
Information
Show Menu
Previous Page 5 / 5
Page Background

allied

academies

Page 14

Notes:

Journal of Clinical Pathology and Laboratory Medicine | Volume 3

July 05-06, 2019 | Paris, France

Pathology and Surgical Pathology

2

nd

International Conference on

C

ancer affects everyone - the young and old, the rich and

poor, men, women and children, about 16% of people die

from cancer, in 2015, 8.8 million people died from cancer-

nearly 1 in 6 global deaths (WHO). The total economic cost

of cancer in 2010 was estimated at approximately $1.16

Trillion. Cancer defined as a disease in which a group of

abnormal cells growuncontrollably the normal cell of division,

continue and spread, it can be fatal, we now define cancer

as a disease involves mutations in the cell genome (DNA

mutations), cancer starts in just one cell, so early laboratory

diagnosis of cancer is very important, ordinary tumor markers

are not enough and using 400-gene test for cancer is difficult

and limited in medical laboratory, miRNAs biomarkers

have become as key molecular components of the cell in

both normal and pathologic states, each tumor type has a

distinct miRNA signature, now there are over 2500 human

miRNAs recorded, the purpose of this work is to design a

one laboratory test for early diagnosis of cancer using small

group of miRNAs as one panel, which need blood sample less

than 1 ml by which patient can check up for many types of

cancer, can do population screening, diagnosis, prognosis,

therapeutic decision making and disease monitoring.

Speaker Biography

Ahmed Abdelhalim Yameny is the head of society of pathological

biochemistry and hematology. He is the chairman of Medical Laboratory

Syndicate in Egypt. He was the chairman for five international conferences

of medical laboratory and four international conferences of the society of

pathological biochemistry and hematology. He is an expert and medical

laboratory consultant. He is chief editor of Journal of Bioscience and

Applied Research; International Journal of Pathology and Biomarkers and

Journal of Medical and Life Science. He has a PhD in Microbiology and has

five high diplomas (bacteriology, public health of parasitology and medical

entomology, analytical biochemistry, hematology and genetic analysis). He

has a BSc in Biochemistry (Alexandria University in Egypt) and he has a BSc

in Biochemistry/Chemistry (Tanta University in Egypt). He is a researcher

and interested in molecular pathology.

e:

dr.ahmedyameny@yahoo.com

Ahmed Abdelhalim Yameny

Society of Pathological Biochemistry and Hematology, Egypt

The role of miRNA in early cancer diagnosis